{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:06:41Z","timestamp":1789776401257,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["287927"],"award-info":[{"award-number":["287927"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["314909"],"award-info":[{"award-number":["314909"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2021069"],"award-info":[{"award-number":["2021069"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["3141-00031A"],"award-info":[{"award-number":["3141-00031A"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["9041-00151A"],"award-info":[{"award-number":["9041-00151A"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PDC2021-121711-100"],"award-info":[{"award-number":["PDC2021-121711-100"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-117323RB-100"],"award-info":[{"award-number":["PID2020-117323RB-100"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jbc.2025.108508","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:06:20Z","timestamp":1744369580000},"page":"108508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction"],"prefix":"10.1016","volume":"301","author":[{"given":"Diego","family":"Pilati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-9327","authenticated-orcid":false,"given":"Eugene Kusi","family":"Agyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-7849","authenticated-orcid":false,"given":"Marwa","family":"Elkhashab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7450-754X","authenticated-orcid":false,"given":"Elisabeth","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Helstrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8337-4136","authenticated-orcid":false,"given":"Tobias Wang","family":"Bjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-4571","authenticated-orcid":false,"given":"Aina Karen","family":"Anthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-1881","authenticated-orcid":false,"given":"Ana\u00efs","family":"Jim\u00e9nez-Reinoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Beck","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1308-8948","authenticated-orcid":false,"given":"Layla","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-2509","authenticated-orcid":false,"given":"Ryo","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Frago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Terje","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5409-045X","authenticated-orcid":false,"given":"S\u00f8ren E.","family":"Degn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren R.","family":"Paludan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3053-6757","authenticated-orcid":false,"given":"Luis","family":"Alvarez-Vallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.108508_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2025.108508_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.108508_bib4","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbc.2025.108508_bib6","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1189\/jlb.0106011","article-title":"Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19","volume":"80","author":"Hoene","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jbc.2025.108508_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2013.10.009","article-title":"Structures of pattern recognition receptors reveal molecular mechanisms of autoinhibition, ligand recognition and oligomerization","volume":"26","author":"Chuenchor","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2025.108508_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2004.02.022","article-title":"Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides","volume":"97","author":"Mutwiri","year":"2004","journal-title":"J. Control Release"},{"key":"10.1016\/j.jbc.2025.108508_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/14760584.2014.863715","article-title":"Recent progress concerning CpG DNA and its use as a vaccine adjuvant","volume":"13","author":"Shirota","year":"2014","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.jbc.2025.108508_bib13","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1016\/j.vaccine.2013.05.068","article-title":"Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age","volume":"31","author":"Heyward","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jbc.2025.108508_bib14","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/acs.bioconjchem.0c00523","article-title":"Immune responses and antitumor effect through delivering to antigen presenting cells by optimized conjugates consisting of CpG-DNA and antigenic peptide","volume":"31","author":"Irie","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2025.108508_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2008.12.012","article-title":"CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases","volume":"61","author":"Klinman","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbc.2025.108508_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol. Cell Ther"},{"key":"10.1016\/j.jbc.2025.108508_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/17425255.2020.1801633","article-title":"Albumin-based drug designs for pharmacokinetic modulation","volume":"16","author":"Pilati","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jbc.2025.108508_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.108508_bib19","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1074\/jbc.M117.794248","article-title":"Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin","volume":"292","author":"Schmidt","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108508_bib20","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1403014","article-title":"FcRn: the architect behind the immune and nonimmune functions of IgG and albumin","volume":"194","author":"Pyzik","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib21","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.166.5.3266","article-title":"MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells","volume":"166","author":"Zhu","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9586","article-title":"Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses","volume":"5","author":"Blumberg","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.108508_bib23","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1182\/blood-2006-05-024539","article-title":"FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis","volume":"108","author":"Vidarsson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.108508_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib25","doi-asserted-by":"crossref","first-page":"34583","DOI":"10.1074\/jbc.M114.587675","article-title":"Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal Fc receptor (FcRn)","volume":"289","author":"Sand","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108508_bib26","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.0801717105","article-title":"Dependence of antibody-mediated presentation of antigen on FcRn","volume":"105","author":"Qiao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.108508_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","article-title":"Regulation of the nucleic acid-sensing Toll-like receptors","volume":"22","author":"Lind","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-017-00695-1","article-title":"BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells","volume":"8","author":"Combes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108508_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpba.2014.12.001","article-title":"Mass spectrometric characterization of human serum albumin dimer: a new potential biomarker in chronic liver diseases","volume":"112","author":"Naldi","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jbc.2025.108508_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41467-018-03061-x","article-title":"A human endothelial cell-based recycling assay for screening of FcRn targeted molecules","volume":"9","author":"Grevys","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108508_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cyto.a.24269","article-title":"Comprehensive phenotyping of human dendritic cells and monocytes","volume":"99","author":"Mair","year":"2021","journal-title":"Cytometry A"},{"key":"10.1016\/j.jbc.2025.108508_bib32","doi-asserted-by":"crossref","first-page":"e176166","DOI":"10.1172\/jci.insight.176166","article-title":"Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin","volume":"9","author":"Ma","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2025.108508_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40265-022-01678-3","article-title":"Efgartigimod: first approval","volume":"82","author":"Heo","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2025.108508_bib34","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s40265-023-01933-1","article-title":"Rozanolixizumab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2025.108508_bib35","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib36","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aa6a9b","article-title":"Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding","volume":"28","author":"Schmokel","year":"2017","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jbc.2025.108508_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/acs.molpharmaceut.5b00605","article-title":"Neonatal Fc receptor binding tolerance toward the covalent conjugation of payloads to cysteine 34 of human albumin variants","volume":"13","author":"Petersen","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jbc.2025.108508_bib38","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","article-title":"Phosphorothioate modified oligonucleotide-protein interactions","volume":"48","author":"Crooke","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.108508_bib39","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2009-08-239202","article-title":"CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells","volume":"115","author":"Guo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.108508_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1365-2567.2002.01410.x","article-title":"Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo","volume":"106","author":"Dalpke","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.jbc.2025.108508_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.108508_bib42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0198-8859(02)00749-8","article-title":"Plasmacytoid dendritic cells: the key to CpG","volume":"63","author":"Rothenfusser","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4049\/jimmunol.175.3.1619","article-title":"3rd. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells","volume":"175","author":"Roda","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib45","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.108508_bib46","doi-asserted-by":"crossref","first-page":"13492","DOI":"10.1074\/jbc.M114.549832","article-title":"Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding","volume":"289","author":"Andersen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108508_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jim.2004.07.006","article-title":"Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function","volume":"293","author":"Reddy","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbc.2025.108508_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2020.12.001","article-title":"Monocyte regulation in homeostasis and malignancy","volume":"42","author":"Robinson","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib49","first-page":"H1394","article-title":"Blood-to-tissue clearance vs. lymph analysis in determining capillary transport characteristics for albumin in skin","volume":"264","author":"Reed","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jbc.2025.108508_bib50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/mvre.1994.1025","article-title":"Limits to steady-state lymph flow rates derived from plasma-to-tissue uptake measurements","volume":"47","author":"Renkin","year":"1994","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jbc.2025.108508_bib51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCRESAHA.116.309828","article-title":"Transcellular pathways in lymphatic endothelial cells regulate changes in solute transport by fluid stress","volume":"120","author":"Triacca","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2025.108508_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/thno.21691","article-title":"An albumin-binding polypeptide both targets cytotoxic T lymphocyte vaccines to lymph nodes and boosts vaccine presentation by dendritic cells","volume":"8","author":"Wang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2025.108508_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304664","article-title":"Lymph node targeting mediated by albumin hitchhiking of synthetic tn glycolipid leads to robust in vivo antibody production","volume":"13","author":"Thekke Veettil","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jbc.2025.108508_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2025.108508_bib55","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.vaccine.2014.06.065","article-title":"Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer","volume":"32","author":"Scheiermann","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jbc.2025.108508_bib56","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41416-022-01876-6","article-title":"Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity","volume":"127","author":"Dongye","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2025.108508_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.590054","article-title":"CpG adjuvant in allergen-specific immunotherapy: finding the sweet spot for the induction of immune tolerance","volume":"12","author":"Montamat","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib58","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1038\/s41467-018-05816-y","article-title":"Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108508_bib59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0161-5890(96)00004-1","article-title":"The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn","volume":"33","author":"Popov","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib60","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","article-title":"The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans","volume":"13","author":"Firan","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib61","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.4049\/jimmunol.1401218","article-title":"Fc engineering of human IgG1 for altered binding to the neonatal Fc receptor affects Fc effector functions","volume":"194","author":"Grevys","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.108508_bib62","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/nbt1143","article-title":"Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels","volume":"23","author":"Vaccaro","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2025.108508_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2015.12.019","article-title":"Generation of a double transgenic humanized neonatal Fc receptor (FcRn)\/albumin mouse to study the pharmacokinetics of albumin-linked drugs","volume":"223","author":"Viuff","year":"2016","journal-title":"J. Control Release"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825003576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825003576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:18:53Z","timestamp":1761841133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825003576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0021925825003576"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108508","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"108508"}}